TickerFactsScreenerDevelopers

Actinium Pharmaceuticals, Inc. (ATNM) — Net Income

Annual figures by fiscal year, from SEC filings.

2001: -$5.09M2002: -$3.19M2003: -$3.53M2004: -$5.73M2005: -$4.58M2006: -$6.05M2007: -$5.62M2008: -$5.57M2009: -$3.43M2010: -$467.3K2011: -$3.44M2012: -$8.36M2013: -$10.77M2014: -$24.69M2015: -$21.03M2016: -$24.32M2017: -$26.60M2018: -$23.65M2019: -$21.90M2020: -$22.21M2021: -$24.77M2022: -$33.02M2023: -$48.82M2024: -$38.24M2025: -$33.89M-$33.89M
2001Net Income (USD)2025
Fiscal YearNet IncomeChange YoY
2025-$33.89M+11.4%
2024-$38.24M+21.7%
2023-$48.82M-47.9%
2022-$33.02M-33.3%
2021-$24.77M-11.5%
2020-$22.21M-1.4%
2019-$21.90M+7.4%
2018-$23.65M+11.1%
2017-$26.60M-9.4%
2016-$24.32M-15.7%
2015-$21.03M+14.8%
2014-$24.69M-129.1%
2013-$10.77M-28.9%
2012-$8.36M-142.7%
2011-$3.44M-637.2%
2010-$467.3K+86.4%
2009-$3.43M+38.5%
2008-$5.57M+0.8%
2007-$5.62M+7.2%
2006-$6.05M-32.2%
2005-$4.58M+20.1%
2004-$5.73M-62.4%
2003-$3.53M-10.6%
2002-$3.19M+37.3%
2001-$5.09M—